Biontech stock.

Find the latest BioNTech SE (BNTX) stock quote, history, news and other vital information to help you with your stock trading and investing. Find the latest BioNTech SE (BNTX) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. Oct 16, 2023 · BioNTech expects to release third-quarter results on Nov. 6. BioNTech's stock has dropped 31.1% year to date through Friday, while Pfizer shares have tumbled 37.3% and the S&P 500 has gained 12.7% ... In my view, it isn't too late to buy BioNTech stock whatsoever, and here's why. Right now, it has 2.3 billion euros in cash, and only 286 million euros in debt. And its trailing 12-month operating ...

Shares of BioNTech SE BNTX, +0.58% dropped 2.4% toward a three-month low in premarket trading Monday, after the Germany-based biotechnology company, which developed a COVID-19 vaccine with partner ...The three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestig...

Discover real-time BioNTech SE American Depositary Share (BNTX) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.

NTLA Intellia Therapeutics, Inc. +0.51%. EDIT Editas Medicine, Inc. NVO Novo Nordisk A/S. +1.25%. View the basic BNTX option chain and compare options of BioNTech SE on Yahoo Finance.BioNTech Stock History. Headquartered in Mainz, Germany, BioNTech is a pharmaceutical company with a history dating back to 2008. Prior to its partnership with Pfizer, the company specialized in ...Stock analysis for BioNTech SE (BNTX:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Company profile page for BioNTech SE including stock price, company news, executives, board members, and contact information.Analysts have set 12-month price targets for BioNTech, revealing an average target of $145.43, a high estimate of $171.00, and a low estimate of $100.00. This upward trend is evident, with the ...

Stock Information Stock Quote & Chart Stock Quote & Chart. Change ... BioNTech SE. An der Goldgrube 12. 55131 Mainz, Germany. T: +49 6131 9084-0. F: +49 6131 9084-2121.

The latest BioNTech stock prices, stock quotes, news, and BNTX history to help you invest and trade smarter.

Analysts have set 12-month price targets for BioNTech, revealing an average target of $145.43, a high estimate of $171.00, and a low estimate of $100.00. This upward trend is evident, with the ...Answering this question will take us one step closer to our new normal. We know that the vaccines now available across the world will protect their recipients from getting sick wit...May 10, 2024 · BioNTech’s stock sinks after earnings miss, as inventory writedowns weigh Mar. 20, 2024 at 7:30 a.m. ET by Tomi Kilgore Biontech 4Q Rev EUR1.48B Jan 20, 2022 · BioNTech stock, a leader in messenger RNA technology and Pfizer’s Covid-19 vaccine partner, declined by almost 31% over the last month, considerably underperforming the S&P 500 which remained ... Business Summary. BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which …You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a br...

Get today's Biontech stock price and latest BNTX stock news as well as Biontech real-time stock quotes, technical analysis, full financials and more.BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is ...BioNTech SE (NASDAQ:BNTX) Q1 2024 Earnings Call Transcript. BioNTech SE (NASDAQ:BNTX) Q1 2024 Earnings Call Transcript May 6, 2024 BioNTech SE isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to BioNTech’s First Quarter 2024 Earnings Call.BioNTech and Pfizer's COVID-19 vaccine, COMIRNATY, generated $36.8 billion in sales in 2021, making it the highest-selling pharmaceutical product in a single year. BioNTech's stock has faced ...Mar 27, 2023 ... Following the news, BioNTech's stock was down 6% in early trading Monday morning ... BioNTech's share of profits in Pfizer and Fosun Pharma ...

Dec 28, 2023 · BioNTech, like all Covid-19 vaccine makers, has gotten crunched in 2023. But it has so much cash that it would have appealed to Warren Buffett’s mentor, famed value manager Benjamin Graham.

Nov 6, 2023 · (RTTNews) - BioNTech SE (BNTX) Monday announced a sharp fall in third-quarter earnings compared to the prior year, as the commercial revenues were down sharply. The company revised down its COVID ... Stock analysis for BioNTech SE (BNTX:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.The average 12-month price target for BioNTech stock right now is $261.95, roughly 25% lower than the current share price. That average is based on Refinitiv's survey of 12 analysts.In today’s fast-paced business world, effective stock management is crucial for any company that deals with software products. Software stock management refers to the process of ov...Complete BioNTech SE ADR stock information by Barron's. View real-time BNTX stock price and news, along with industry-best analysis.Mar. 20, 2024 7:05 AM ET BioNTech SE (BNTX) Stock, PFE Stock By: Dulan Lokuwithana, SA News Editor 9 Comments. BioNTech ( NASDAQ: BNTX ), the partner of Pfizer ( NYSE: PFE) for Comirnaty COVID-19 ...Find the latest BioNTech SE (BNTX) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.

BioNTech SE is a Germany-based biotechnology company that develops and manufactures immunotherapies for cancer, infectious diseases, allergies and …

6 days ago · Stock analysis for BioNTech SE (BNTX:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

BioNTech. BioNTech SE ( / biːˈɒntɛk / bee-ON-tek; or / baɪˈɒntɛk / bye-ON-tek [2] short for Biopharmaceutical New Technologies) is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases. Cash Amount. Record Date. Pay Date. Jun 2, 2022. $2.111. Jun 3, 2022. Jun 17, 2022. * Dividend amounts are adjusted for stock splits when applicable. Get the latest dividend data for BioNTech SE (BNTX), including dividend history, yield, key dates, growth and other metrics.Get the latest BioNTech SE - ADR (22UA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Find the latest BioNTech SE (BNTX) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. Get today's Biontech stock price and latest BNTX stock news as well as Biontech real-time stock quotes, technical analysis, full financials and more.Interactive Chart for BioNTech SE (BNTX), analyze all the data with a huge range of indicators.BioNTech Analyst EPS Estimates. BioNTech last announced its quarterly earnings results on March 20th, 2024. The reported $2.05 earnings per share for the quarter, missing the consensus estimate of $2.64 by $0.59. The company had revenue of $1.59 billion for the quarter, compared to analysts' expectations of $2.04 billion.BioNTech SE (/ b iː ˈ ɒ n t ɛ k / bee-ON-tek; or / b aɪ ˈ ɒ n t ɛ k / bye-ON-tek short for Biopharmaceutical New Technologies) is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases. It develops pharmaceutical candidates based on messenger …About BioNTech SE. BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June ...0. 0. In the last 3 months, 5 analysts have offered 12-month price targets for BioNTech. The company has an average price target of $129.0 with a high of $180.00 and a low of $110.00. Below is a ...

Mar 21, 2024 · Analysts have set 12-month price targets for BioNTech, revealing an average target of $145.43, a high estimate of $171.00, and a low estimate of $100.00. This upward trend is evident, with the ... Get the latest BioNTech SE - ADR (22UA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.NEW YORK and MAINZ, GERMANY, MAY 26, 2023 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have reached an agreement with the European Commission (EC) to amend their existing contract to deliver COVID-19 vaccines to the European Union.. The amended agreement reflects the …Because of that gap in time -- and the risk of failures during clinical trials -- determining whether BioNTech stock is a buy is less about valuation and more about the open-ended potential of a ...Instagram:https://instagram. what's my phone number on this phonehow to take a screenshot on a samsung phoneyou. comhow to scan a qr code on your screen 1. Enter the amount you'd like to invest in BioNTech stock, then proceed to checkout. Stash allows you to purchase smaller, more affordable pieces of investments (called fractional shares) rather than the whole share, which can be significantly more expensive. BioNTech ’s share price is determined by its bid-ask spread, which is the ... secureserver netwww.suncoastcreditunion.com online banking BioNTech, a leader in messenger RNA technology and Pfizer’s Covid-19 vaccine partner, has seen its stock decline by about 2% over the last week (five trading days) and also remains down by about ... how to open a .dat file BioNTech SE (/ b iː ˈ ɒ n t ɛ k / bee-ON-tek; or / b aɪ ˈ ɒ n t ɛ k / bye-ON-tek short for Biopharmaceutical New Technologies) is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases. It develops pharmaceutical candidates based on messenger …BioNTech Stock: Forecast In Line With Street's Outlook. But the company kept its outlook for the year, and expects 2.5 billion to 3.1 billion euros, or about $2.7 …